EPOXYQUINOMICIN-C
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 3Nlji3qiibt |
|---|---|
| InChI | InChI=1S/C14H13NO6/c16-6-14-10(18)5-8(11(19)12(14)21-14)15-13(20)7-3-1-2-4-9(7)17/h1-5,11-12,16-17,19H,6H2,(H,15,20)/t11-,12+,14-/m0/s1 |
| InChIKey | JNDISHBDOZQLTR-SCRDCRAPSA-N |
| Mol Weight | 291.26 g/mol |
| Molecular Formula | C14H13NO6 |
| Exact Mass | 291.074287 g/mol |
| Enantiomer InChIKey | JNDISHBDOZQLTR-MBNYWOFBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
1-(5-Benzamido-5-deoxy-2,3-epoxy-B-D-lyxofuranosyl)-uracil
2-(Hexa-2'E,4'RE-dienamido)-4-(triisopropylsilylhepta-1"E,3"E,5"E-trienoate)-4-hydroxy-5,6-epoxycyclohex-2-en-1-one
N,N-diethyl-2,3,4-trimethoxy-6-(2-methylallyl)benzamide
(2S,3S,4R,5R)-1-[(tert-butyldimethylsilyl)oxy]-2,3-(isopropylidenedioxy)-5-[[[p-(methoxybenzyl)oxy]carbonyl]amino]-4,6-bis(methoxymethoxy)hexane
benzamide, N-[[5-[(4,7-dimethoxy-1,3-benzodioxol-5-yl)methyl]-4,5-dihydro-3-isoxazolyl]methyl]-3-fluoro-
2H-1-Benzopyran-2-one, 5,7-dimethoxy-3-[(2-oxo-2H-1-benzopyran-3-yl)carbonyl]-
(.+-.)-2T,3T-Epoxy-4c-phthalimido-cyclohexyl trichloroacetimidate
2-Oxazolidinone, 3-[5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-methoxy-2,4,6,7-tetramethyl-1-oxo-7-octenyl]-4-(1-methylethyl)-, [4S-[3(2R*,3S*,4R*,5R*,6S*),4R*]]-
N-(1)-[(3AS,4R,7S,7AS)-2,2,7-TRIMETHYL-3A,4,7,7A-TETRAHYDRO-1,3-BENZODIOXOL-4-YL]-BENZAMIDE
2-(4-chlorophenyl)-3-(3-{2-methoxy-4-[(1E)-1-propenyl]phenoxy}propyl)-4(3H)-quinazolinone
| Title | Journal or Book | Year |
|---|---|---|
| Epoxyquinomicins A, B, C and D, New Antibiotics from Amycolatopsis. III. Physico-chemical Properties and Structure Determination. | The Journal of Antibiotics | 1997 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.